Integrin α4 (ITGA4), for which increased expression has been previously associated with very poor outcomes in BCP-ALL 66, was the only integrin out of the ten detected that was upregulated in MLL-r cells at the transcript level. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.